Basu et al. [26] conducted a single center, prospective, randomized, double-blind study in which 65 subjects with CLD and thrombocytopenia (baseline platelet count of <60,000/μL) received a TPO agonist or platelets transfusion prior to undergoing a percutaneous liver biopsy. This evidence concerns the gene TPO and Thrombocytopenia.